GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cilo Cybin Holdings Ltd (JSE:CCC) » Definitions » Interest Coverage

Cilo Cybin Holdings (JSE:CCC) Interest Coverage : 0 (At Loss) (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Cilo Cybin Holdings Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Cilo Cybin Holdings's Operating Income for the six months ended in Sep. 2024 was R-1.62 Mil. Cilo Cybin Holdings's Interest Expense for the six months ended in Sep. 2024 was R-0.00 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Cilo Cybin Holdings's Interest Coverage or its related term are showing as below:


JSE:CCC's Interest Coverage is not ranked *
in the Drug Manufacturers industry.
Industry Median: 11.98
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Cilo Cybin Holdings Interest Coverage Historical Data

The historical data trend for Cilo Cybin Holdings's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Cilo Cybin Holdings Interest Coverage Chart

Cilo Cybin Holdings Annual Data
Trend Mar22 Mar23
Interest Coverage
No Debt -

Cilo Cybin Holdings Semi-Annual Data
Mar22 Mar23 Sep23 Sep24
Interest Coverage No Debt No Debt - -

Competitive Comparison of Cilo Cybin Holdings's Interest Coverage

For the Drug Manufacturers - Specialty & Generic subindustry, Cilo Cybin Holdings's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cilo Cybin Holdings's Interest Coverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cilo Cybin Holdings's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Cilo Cybin Holdings's Interest Coverage falls into.


;
;

Cilo Cybin Holdings Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cilo Cybin Holdings's Interest Coverage for the fiscal year that ended in Mar. 2023 is calculated as

Here, for the fiscal year that ended in Mar. 2023, Cilo Cybin Holdings's Interest Expense was R-0.01 Mil. Its Operating Income was R-0.54 Mil. And its Long-Term Debt & Capital Lease Obligation was R0.00 Mil.

Cilo Cybin Holdings did not have earnings to cover the interest expense.

Cilo Cybin Holdings's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Here, for the six months ended in Sep. 2024, Cilo Cybin Holdings's Interest Expense was R-0.00 Mil. Its Operating Income was R-1.62 Mil. And its Long-Term Debt & Capital Lease Obligation was R0.00 Mil.

Cilo Cybin Holdings did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Cilo Cybin Holdings  (JSE:CCC) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Cilo Cybin Holdings Interest Coverage Related Terms

Thank you for viewing the detailed overview of Cilo Cybin Holdings's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Cilo Cybin Holdings Business Description

Traded in Other Exchanges
N/A
Address
7 Sterling Street, The Point Office Park, Unit C1, Samrand, Pretoria, GT, ZAF, 0157
Cilo Cybin Holdings Ltd is a Company whose core focus is on supplying GMP medical cannabis products, including GMP CBD, CBG, CBN isolates and GMP THC and CBD distillates to meet the highest standards of quality, effectiveness, care, and safety. It specializes in supplying medical-grade cannabis flower and final products, using a cold ethanol extraction process with high-quality input materials.

Cilo Cybin Holdings Headlines

No Headlines